Today: 17 April 2026
Dow Jones at 49,500 after softer CPI — what to watch before Wall Street’s next session
14 February 2026
1 min read

Dow Jones at 49,500 after softer CPI — what to watch before Wall Street’s next session

New York, February 14, 2026, 12:15 (EST) — The market has closed.

The Dow Jones Industrial Average (.DJI) added 48.95 points, or 0.1%, to finish Friday at 49,500.93. Despite the late lift, the blue-chip index dropped 1.2% for the week. The S&P 500 lost 1.4% and the Nasdaq Composite sank 2.1% this week, even as smaller stocks managed a stronger showing on Friday.

Investors took solace from a softer-than-expected inflation reading in January. Data showed the consumer price index climbed just 0.2%, while core CPI, stripping out food and energy, advanced 0.3%. Year-on-year, core CPI rose 2.5%—the smallest gain in almost five years. “The direction of travel for inflation continues to look to be lower,” said James McCann, senior economist at Edward Jones. Still, he warned the road ahead could prove “bumpy.” Reuters

That support gave some relief to rate-sensitive sectors, but tech remained under pressure. “Large cap tech stocks continue to be an anchor on the market, and any whiff of optimism continues to get rejected,” said Michael James, managing director at Rosenblatt Securities. Traders put the chance of a 25-basis-point cut in June at 52.3%, according to CME’s FedWatch tool. With the NYSE closed Monday for Washington’s Birthday, the main U.S. indexes just logged their biggest weekly drops since November. Reuters

Bond yields slipped on the heels of the inflation numbers. The 10-year Treasury yield, which influences everything from mortgages to business loans, dropped to 4.05% following the CPI release. It had ended Thursday at 4.11%.

Dow movers showed little consensus. Nike, UnitedHealth, and Walt Disney landed in positive territory, but Apple, Visa, and 3M lagged behind, according to Markets Insider data.

Still, inflation’s outlook isn’t clear-cut, so the risk of a pullback sticks around. Economists speaking with the Financial Times flagged potential distortions muddying the inflation numbers after the U.S. government shutdown. Add to that January’s jobs report: 130,000 new jobs, nearly twice what was expected. It’s the sort of mix that could easily keep the Fed on alert. If the numbers heat up again, yields can jump and stocks could feel the squeeze in a hurry.

Walmart, a Dow component, plans to roll out its fiscal fourth-quarter earnings at roughly 6 a.m. U.S. Central on Feb. 19, the company’s investor events page shows. A conference call is slated for 7 a.m.

After the holiday lull, the market’s looking ahead to a fresh set of data. On Tuesday, the New York Fed’s Empire State manufacturing index is on tap, along with the NAHB’s latest read on the housing market. Fed minutes hit Wednesday. Then Friday brings a heavy slate: the first take on fourth-quarter GDP, the core PCE price index — the inflation measure the Fed watches closest — and the flash PMI surveys for a quick pulse on business momentum.

Stock Market Today

  • Axon Enterprise Shares Show Volatility but Fairly Valued on DCF Model
    April 16, 2026, 11:07 PM EDT. Axon Enterprise's stock has swung sharply, with a 29.7% drop over 12 months but a 75.1% gain over three years. The shares trade around $393, near the estimated intrinsic value of $381 from a Discounted Cash Flow (DCF) analysis, which values future free cash flow. This suggests the stock is roughly fairly valued, with a small 3.2% overvaluation margin that is typical for such models. Axon scores low on valuation metrics, reflecting investor caution amid its ongoing growth investments. Market participants should watch these dynamics closely, as DCF intrinsic value and sales-based price multiples offer different perspectives on the company's worth amid share price fluctuations.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus
Previous Story

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus

Nebius stock pops 9%: $7-$9B run-rate target and France data centre plan put NBIS in focus
Next Story

Nebius stock pops 9%: $7-$9B run-rate target and France data centre plan put NBIS in focus

Go toTop